Requesting the Auditor to assess the social and financial effects of mandatory health insurance coverage for biomarker testing.
Biomarker testing, which analyzes a patient's biospecimen for genes, proteins, and other substances, is crucial for personalized medical care. This bill requests the Auditor to evaluate the social and financial impacts of mandating health insurance coverage for medically necessary biomarker testing, as proposed in House Bill No. 1971. The Auditor's report, due before the 2027 Regular Session, will include findings and recommendations, potentially guiding future legislation.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.